Items where authors include "Brown, SR"

Article

Brown, SR orcid.org/0000-0002-7975-7537, Hinsley, S, Hall, E et al. (5 more authors) (2022) A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations. Clinical Cancer Research, 28 (17). pp. 3639-3651. ISSN 1078-0432

Winter, M, Coleman, R, Kendall, J orcid.org/0000-0003-2884-4849 et al. (13 more authors) (2022) A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results. Journal of Bone Oncology, 35. 100442. ISSN 2212-1374

Auner, HW, Brown, SR orcid.org/0000-0002-7975-7537, Walker, K et al. (9 more authors) (2022) Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results. Blood Cancer Journal, 12 (4). 52. ISSN 2044-5385

Abbas, A, Schini, M, Ainsworth, G orcid.org/0000-0002-9952-8440 et al. (7 more authors) (2022) Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia. Journal of Clinical Endocrinology and Metabolism. ISSN 0021-972X

Jayne, DG orcid.org/0000-0002-8725-3283, Williams, AE, Corrigan, N orcid.org/0000-0002-1424-9830 et al. (16 more authors) (2021) Sacral nerve stimulation versus the magnetic sphincter augmentation device for adult faecal incontinence: the SaFaRI RCT. Health Technology Assessment, 25 (18). pp. 1-96. ISSN 1366-5278

Buckley, HL orcid.org/0000-0002-9829-5817, Collinson, FJ, Ainsworth, G et al. (15 more authors) (2019) PRISM protocol: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. BMC Cancer, 19. ARTN: 1102. ISSN 1471-2407

Brown, SR, Hall, A, Buckley, H orcid.org/0000-0002-9829-5817 et al. (9 more authors) (2019) Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial. BMC Cancer, 19 (1). ARTN: 582. ISSN 1471-2407

Popat, R, Brown, SR, Flanagan, L et al. (10 more authors) (2019) Extended follow‐up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi‐centre phase I/II Clinical Trial). British Journal of Haematology, 185 (3). pp. 573-578. ISSN 0007-1048

Cook, G orcid.org/0000-0003-0223-3652, Royle, K-L, Pawlyn, C et al. (10 more authors) (2019) A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study. Lancet Haematology, 6 (3). pp. 154-166. ISSN 2352-3026

Brown, SR, Sherratt, D, Booth, G et al. (4 more authors) (2017) Experiences of Establishing an Academic Early Phase Clinical Trials Unit. Clinical Trials, 14 (4). pp. 349-356. ISSN 1740-7745

Wadsley, J, Gregory, R, Flux, G et al. (6 more authors) (2017) SELIMETRY- A Multicentre I-131 Dosimetry Trial: A Clinical Perspective. British Journal of Radiology, 90 (1073). 20160637. ISSN 0007-1285

Popat, R, Brown, SR, Flanagan, L et al. (9 more authors) (2016) Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial. The Lancet Haematology, 3 (12). e572-e580. ISSN 2352-3026

Sharma, RA, Plummer, R, Stock, JK et al. (36 more authors) (2016) Clinical development of new drug-radiotherapy combinations. Nature Reviews Clinical Oncology, 13 (10). pp. 627-642. ISSN 1759-4774

Wilson, DT, Walwyn, REA, Brown, J et al. (2 more authors) (2016) Statistical challenges in assessing potential efficacy of complex interventions in pilot or feasibility studies. Statistical Methods in Medical Research, 25 (3). pp. 997-1009. ISSN 0962-2802

Richman, SD orcid.org/0000-0003-3993-5041, Southward, K, Chambers, P orcid.org/0000-0002-0926-717X et al. (16 more authors) (2016) HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: Analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials. Journal of Pathology, 238 (4). pp. 562-570. ISSN 0022-3417

Williams, AE, Croft, J, Napp, V et al. (7 more authors) (2016) SaFaRI: sacral nerve stimulation versus the FENIX (TM) magnetic sphincter augmentation for adult faecal incontinence: a randomised investigation. International Journal of Colorectal Disease, 31 (2). pp. 465-472. ISSN 0179-1958

Schey, S, Brown, SR, Tillotson, A-L et al. (13 more authors) (2015) Bendamustine, thalidomide and dexamethasone combinationtherapy for relapsed/refractory myeloma patients: results ofthe MUKone randomized dose selection trial. British Journal of Haematology, 170 (3). pp. 336-348. ISSN 0007-1048

Brown, SR, Mathew, R, Keding, A et al. (3 more authors) (2014) The impact of postoperative complications on long-term quality of life after curative colorectal cancer surgery. Annals of Surgery, 259 (5). 916 - 923. ISSN 0003-4932

Seymour, MT, Brown, SR, Middleton, G et al. (18 more authors) (2013) Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial. The Lancet Oncology, 14 (8). 749 - 759. ISSN 1470-2045

Coates, LC, Navarro-Coy, N, Brown, SR et al. (11 more authors) (2013) The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskeletal Disorders, 14. 101. ISSN 1471-2474

Brown, SR, Gregory, WM, Twelves, CJ et al. (5 more authors) (2011) Designing phase II trials in cancer: a systematic review and guidance. British Journal of Cancer, 105 (2). 194 - 199 . ISSN 1532-1827

Taylor, GW, Jayne, DG, Brown, SR et al. (5 more authors) (2010) Adhesions and incisional hernias following laparoscopic versus open surgery for colorectal cancer in the CLASICC trial. British Journal of Surgery, 97 (1). 70 - 78. ISSN 1365-2168

Thorpe, HC, Brown, SR, Sainsbury, JR et al. (5 more authors) (2007) Timing of breast cancer surgery in relation to menstrual cycle phase: No effect on three-year prognosis: The ITS Study. British Journal of Cancer, 98 (1). 39 - 44. ISSN 0007-0920

Conference or Workshop Item

Garg, M, Hall, A, Jenner, M et al. (10 more authors) (2019) A Phase 1 Study of Carfilzomib-Thalidomide-Dexamethasone in Patients with Relapsed/Refractory AL Amyloidosis - Catalyst Trial Results. In: 61st ASH (American Society of Hematology) Annual Meeting & Exposition, 07-10 Dec 2019, Orlando, FL.

Proceedings Paper

Croft, J, Hall, A, Walker, K et al. (11 more authors) (2018) Cyclophosphamide Exerts Significant Immunomodulatory Function in Myeloma Patients Treated with Pomalidomide and Dexamethasone. In: Blood. ASH 2018 60th American Society of Hematology Annual Meeting and Exposition, 01-04 Dec 2018, San Diego, CA. American Society of Hematology , p. 4482.